FORTRESS BIOTECH

Welcome to the Brand page for “FORTRESS BIOTECH”, which is offered here for Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, alzheimer¿s disease, huntington¿s disease, parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;biotech;.

Its status is currently believed to be active. Its class is unavailable. “FORTRESS BIOTECH” is believed to be currently owned by “FORTRESS BIOTECH, INC.”